Qatar Investment Authority logo

Qatar Investment Authority

Asia, Ad Dawhah, Qatar, Doha

Description

The Qatar Investment Authority (QIA) is the sovereign wealth fund of Qatar, established in 2005 to strengthen the country's economy by diversifying its investments globally and generating long-term returns for future generations. With assets under management estimated to be around $500 billion as of early 2024, QIA is one of the world's largest and most influential institutional investors. Its mandate is to protect and grow Qatar's financial assets, moving beyond reliance on hydrocarbon revenues.

Investor Profile

Qatar Investment Authority has backed more than 84 startups, with 19 new investments in the last 12 months alone. The firm has led 29 rounds, about 35% of its total and boasts 33 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series D rounds (top funding stages).
  • Majority of deals are located in United States, India, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 9 rounds in the past year.
  • Typical check size: $100M – $5000M.

Stage Focus

  • Series C (19%)
  • Series B (15%)
  • Series D (14%)
  • Private Equity (14%)
  • Series Unknown (12%)
  • Series E (5%)
  • Series J (4%)
  • Series G (4%)
  • Series F (4%)
  • Series I (2%)

Country Focus

  • United States (56%)
  • India (11%)
  • United Kingdom (10%)
  • Germany (7%)
  • China (6%)
  • Switzerland (4%)
  • Singapore (2%)
  • France (1%)
  • South Korea (1%)
  • Turkey (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Artificial Intelligence (Ai)
  • Therapeutics
  • Biopharma
  • Machine Learning
  • Life Science
  • Software
  • Financial Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qatar Investment Authority frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 7
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 9
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 7
GIC
Asia, Central Region, Singapore, Singapore
Co-Investments: 6
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 8
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 7
BlackRock
North America, New York, United States, New York
Co-Investments: 7
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 7
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 8
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 13

Which angels does Qatar Investment Authority often collaborate with?

JA
North America, California, United States, San Francisco
Shared Deals: 1
Razmig Hovaghimian
North America, Quintana Roo, Mexico, San Francisco
Shared Deals: 1
HM
North America, New Providence, Bahamas, Nassau
Shared Deals: 1
CF
North America, Illinois, United States, Chicago
Shared Deals: 1
SS
Europe, England, United Kingdom, London
Shared Deals: 1
SP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Qatar Investment Authority?

d-Matrix

Santa Clara, California, United States

D-Matrix is a platform that enables data centers to handle large-scale generative AI inference with high throughput and low latency.

Artificial Intelligence (AI)Cloud InfrastructureData CenterSemiconductor
Series CNov 12, 2025
Amount Raised: $275,000,000
Iambic

San Diego, California, United States

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics
Series UnknownNov 10, 2025
Amount Raised: $100,000,000
Synchron

Brooklyn, New York, United States

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

Information TechnologyManufacturingMedicalMedical Device
Series DNov 6, 2025
Amount Raised: $200,000,000
Kailera Therapeutics

Waltham, Massachusetts, United States

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 14, 2025
Amount Raised: $600,000,000
Isagen

Medellín, Antioquia, Colombia

Isagen is a cleantech company dedicated to energy generation, construction of projects and commercialization of energy solutions.

CleanTechConstructionEnergy
Private EquityOct 12, 2025
Amount Raised: $1,535,000,000
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series DSep 30, 2025
Amount Raised: $125,000,000
Ensoma

Boston, Massachusetts, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

BiotechnologyGeneticsLife ScienceMedicalOncologyTherapeutics
Series UnknownSep 22, 2025
Amount Raised: $53,000,000
Ivanhoe Mines

Vancouver, British Columbia, Canada

Ivanhoe Mines operates as a mineral exploration and development company.

AssociationMineralMining
Post Ipo EquitySep 17, 2025
Amount Raised: $500,000,000
PsiQuantum

Palo Alto, California, United States

PsiQuantum focuses on developing a scalable quantum computer using photonic qubits.

ComputerHardwareQuantum ComputingSemiconductorSoftware
Series ESep 10, 2025
Amount Raised: $1,000,000,000
Anthropic

San Francisco, California, United States

Anthropic is an AI research company that focuses on the safety and alignment of AI systems with human values.

Artificial Intelligence (AI)Generative AIInformation TechnologyMachine Learning
Series FSep 2, 2025
Amount Raised: $13,000,000,000